Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction

ASN Neuro. 2011 Mar 24;3(1):e00053. doi: 10.1042/AN20100035.

Abstract

The ability of an AEF (axolemma-enriched fraction) to influence the proliferation, survival and differentiation of OPC (oligodendrocyte progenitor cells) was evaluated. Following addition of AEF to cultured OPC, the AEF associated with the outer surface of OPC so that subsequent metabolic events were likely mediated by direct AEF-OPC contact. Addition of AEF to the cultured OPC resulted in a dose- and time-dependent increase in proliferation that was partially dependent on Akt (protein kinase B) and MAPK (mitogen-activated protein kinase) activation. The major mitogen in an AEF-SE (soluble 2.0 M NaCl extract of the AEF) was identified as aFGF (acidic fibroblast growth factor) and accounted for 50% of the mitogenicity. The remaining 50% of the mitogenicity had properties consistent with bFGF (basic fibroblast growth factor) but was not unequivocally identified. Under conditions that limit the survival of OPC in culture, AEF treatment prolonged the survival of the OPC. Antigenic and morphological examination of the AEF-treated OPC indicated that the AEF treatment helped the OPC survive in a more immature state. The potential downstream metabolic pathways potentially activated in OPC by AEF and the consequences of these activated pathways are discussed. The results of these studies are consistent with the view that direct contact of axons with OPC stimulates their proliferation and survival while preventing their differentiation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Animals, Newborn
  • Cell Count / methods
  • Cell Differentiation / physiology
  • Cell Proliferation
  • Cells, Cultured
  • Cellular Structures / metabolism*
  • Chromatography, Agarose / methods
  • Hot Temperature
  • Mitogen-Activated Protein Kinases
  • Mitogens / pharmacology
  • Neurons / physiology
  • Oligodendroglia / physiology*
  • Proto-Oncogene Proteins c-akt
  • Rats
  • Rats, Sprague-Dawley
  • Schwann Cells / chemistry*
  • Schwann Cells / metabolism
  • Stem Cells / drug effects*
  • Stem Cells / immunology
  • Stem Cells / physiology*
  • Trypsin / pharmacology

Substances

  • Mitogens
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinases
  • Trypsin